• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Note From the Editor-in-Chief

Note From the Editor-in-Chief

March 1, 2018
Daniel Carlat, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Daniel Carlat, MD Editor-in-Chief, The Carlat Psychiatry Report
We publish an issue on antipsychotics at least once a year, and it’s always a challenge to decide what to cover. There are dozens of antipsychotics, and most of them are approved for mood disorders as well as psychosis. I was lucky to be able to speak with Dr. Thomas Schwartz, whose wealth of clinical knowledge on neuroleptic use is astounding. He has some excellent advice on how to monitor and manage metabolic side effects—especially for the likes of olanzapine and risperidone. He also has some comments on when to consider using the newest neuroleptics. We then move to an oldie but goodie: clozapine, a potentially dangerous but extremely effective drug for treatment-resistant schizophrenia. We update you on how to safely prescribe it, along with a straightforward approach to monitoring side effects. And finally, we cover the “Big Brother” pill, Abilify MyCite, concluding that this digital pill sounds much spookier than it actually is. It’s innovative and may be the forerunner of medications of the future, but it’s hard to imagine too many patients for whom its expense will justify its use. All in all, I think this issue shaped up pretty nicely—let me know if you agree.

Best,
Danny Carlat
dcarlat@thecarlatreport.com
General Psychiatry
KEYWORDS antipsychotics
    Carlat 150x150
    Daniel Carlat, MD

    Prescribing Psychotropics: From Drug Interactions to Pharmacogenetics (2022)

    More from this author
    www.thecarlatreport.com
    Issue Date: March 1, 2018
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test - Antipsychotics Update, TCPR, March 2018
    Note From the Editor-in-Chief
    Clozapine: A Fresh Look
    Abilify MyCite: Patient Care Breakthrough or Patent Extender?
    Prescribing and Managing Antipsychotics
    QTc Prolongation Risk Management in Hospital Patients
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • therapist_canstockphoto9201097.jpg
      General Psychiatry

      Using SAMe In Clinical Practice with Garrett Rossi, MD

      Read More
    Featured Podcast
    • canstockphoto6759394.jpg
      General Psychiatry

      Throwback Thursday: Brief Therapy for ADHD

      You started a stimulant medication for a young woman with ADHD. When she returns her symptoms are 70% better, but what can we do about the rest? Today a conversation with...

      Listen now
    Recommended
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    info@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.